UNSPSC 41202053: Rickettsia serological reagents

In this classification, Rickettsia serological reagents are devices used in test to identify specific Rickettsia antibodies in serum. US FDA regulates Rickettsia serological reagents under 21 CFR 866.3500 and under FDA product code GPS.

UNSPSC 41202053 Rickettsia serological reagents is a Commodity code under which state and local governments procure blood-based diagnostic testing reagents and related screening supplies for disease surveillance and criminal justice specimen analysis. Recent state and local solicitations reveal that the code captures HIV, Syphilis, and Hepatitis testing reagents; rapid HIV test kits; and ancillary diagnostic supplies rather than Rickettsia-specific serology alone. Issuing bodies include county corrections and supervision departments, municipal public health agencies, state departments of public health, and university health centers. County community supervision and corrections departments are active repeat buyers, soliciting comprehensive offender specimen collection and drug testing services that encompass immunoassay screening with LC/MS/MS or GC/MS confirmation. State public health laboratories drive demand for high-volume reagent procurement tied to CLIA-certified laboratory operations and disease control surveillance mandates.

Activity concentrates in Texas and Illinois. Collin County Community Supervision and Corrections Department issued RFP 2026-327 for offender specimen collection and drug testing services with an estimated contract value of $600,000 and response due July 23, 2026, covering approximately 25,031 annual tests across five-panel and six-panel screening with confirmation methodologies. The City of Austin released IFB 9100AAM1023 on June 15, 2026, for rapid HIV 1/2 test kits (Abbott Determine product line) supporting the Austin Public Health Program, due July 17, 2026. The Illinois Department of Public Health issued IFB 26482DPHOFCDIB50489 on February 13, 2026, establishing a five-year contract for fully automated Hepatitis/HIV/Syphilis combination screening assays with estimated annual volumes of 3,300 Hepatitis B tests, 3,000 Hepatitis C tests, 13,200 HIV tests, and 11,000 Syphilis tests, due March 16, 2026. IDPH also conducted two emergency sole-source procurements to Abbott Laboratories for HIV and Syphilis reagents and instrumentation supplies in February and May 2026, totaling $38,079.50 across both transactions. The Texas Department of Criminal Justice solicited forensic analysis laboratory services (RFP 696-IG-26-P034) requiring serology and DNA testing capabilities for inmate-related evidence, due May 13, 2026.